The behavior of immune cells in the blood is so different in patients with Parkinson’s disease that it advocate for a new type of supplementary medicine, which can regulate the immune system and thus inhibit the deterioration of the brain.
The behavior of immune cells in the blood is so different in patients with Parkinson’s disease that it advocate for a new type of supplementary medicine, which can regulate the immune system and thus inhibit the deterioration of the brain.